Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases. RESEARCH DESIGN AND METHODS—We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect. RESULTS—We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat–fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14−/− mutant mice mimicked the metabolic and inflammatory effects of antibiotics. CONCLUSIONS—This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacterial translocation can be defined as the passage of bacteria, or bacterial products such as LPS, into the portal circulation and happens when the complex regulation of the mechanisms of the gut barrier is lost [276], which has been linked with the occurrence of NAFLD, NASH, hepatic fibrosis, and HCC in several rodent models [227,228,277].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [276]
In the citing paper
“Penetration of lipopolysaccharide into the bloodstream is controlled by the integrity of the gut barrier.”
From Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016) · cites this paper as [48]
In the citing paper
“In obese rodents, antibiotics and prebiotics were able to restore gut barrier integrity and metabolic functions, providing evidence for the gut barrier as a mediator of microbiota-induced systemic inflammation [98,99].”
Citations
Cites
1 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826 · cited 3×
“We and others have recently demonstrated that the mechanisms of highfat diet-induced inflammation and metabolic disorders were clearly linked to LPS (4;24-28).”
BackgroundResultRetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 7×
“Inflammation: PAI-1, IL-1, and TNF- mRNA concentrations (A, D and G); oxidative stress: STAMP-2 and NADPHox mRNA concentrations (B and E); macrophage infiltration markers: MCP-1 and F4/80 mRNA concentrations (C and F) in mice fed normal diet (CT), normal diet and antibiotics (CT-Ab), high-fat diet (HF), or high-fat di…”
ResultInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown (2,3).”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“Gut microbiota has recently been proposed as an environmental factor involved in the control of body weight and energy homeostasis (7-12).”
BackgroundResultMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 16×
“Although the reasons for its increase in plasma during high-fat feeding were undetermined, its levels were closely correlated but not causatively demonstrated, with changes in intestinal microbiota where the Gram negative–to–Gram positive ratio increased during high-fat feeding (4).”
BackgroundMethodResultSelf-citationThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Germ-free mice of the same age and genetic background as conventional mice fed with a normal chow diet had a 40% lower weight (11), whereas germ-free mice colonized with the gut microbiota derived from the conventional mice increased their fat mass and developed insulin resistance within 2 weeks.”
BackgroundObesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“These animals are characterized by different gut microbiota (8,12), higher inflammatory tone, and endotoxemia when compared with wild-type mice (23).”
BackgroundIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“Oxidative stress is frequently associated with inflammation and metabolic dysfunction in adipose depots (20-22).”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Diabetes 57:1470–1481, 2008 Environmental factors, such as a fat-enriched diet and a sedentary lifestyle, are the causes of the great prevalence of obesity and type 2 diabetes in the population (1).”
Background
Cited by
Items 701–800 of 1,065
Maynard, C., & Weinkove, D. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_12 · Cited by 177
Hydroxycinnamic acids and human health: recent advances
Coman, V., & Vodnar, D. C. (2019) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.10010 · Cited by 173
Bomhof, M. R., Saha, D. C., Reid, D. T., Paul, H. A., & Reimer, R. A. (2014) · Obesity · doi:10.1002/oby.20632 · Cited by 150
“This lower body fat % is one possible explanation why we did not find the significant changes in gut barrier integrity and endotoxemia that has been observed in other studies with ob/ob mice (20,21).”
MethodResultPediatric non-alcoholic fatty liver disease: an increasing public health issue
Berardis, S., & Sokal, E. M. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2157-6 · Cited by 163
“Studies undertaken on NAFLD animal models suggested that probiotics may reduce liver inflammation and improve gut epithelial barrier function [13, 18].”
BackgroundDrug–gut microbiota interactions: implications for neuropharmacology
Walsh, J., Griffin, B. T., Clarke, G., & Hyland, N. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14366 · Cited by 149
“The gut microbiota challenges the intestinal barrier function via induced alterations in intestinal pH and effects on intestinal epithelial integrity (Cani et al., 2008; Carvalho et al., 2012).”
BackgroundPossible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders
Maioli, T. U., Borras-Nogues, E., Torres, L., Barbosa, S. C., Martins, V. D., Langella, P., Azevedo, V. A., & Chatel, J.-M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.740636 · Cited by 149
“These changes were also dependent on changes in the microbiota (Cani et al., 2008b; Amar et al., 2011).”
BackgroundInfluentialJin, Y., Zeng, Z., Wu, Y., Zhang, S., & Fu, Z. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv115 · Cited by 148
“related to the occurrence of host inflammation (Cani et al., 2008; Loubinoux et al., 2000; Porschen and Chan, 1977), could lead to gut barrier function damage and, finally, resulted in host inflammation and metabolic disorder (Zhang et al.”
BackgroundLee, C. B., Chae, S. U., Jo, S. J., Jerng, U. M., & Bae, S. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073566 · Cited by 165
Letchumanan, G., Abdullah, N., Marlini, M., Baharom, N., Lawley, B., Omar, M. R., Mohideen, F. B. S., Addnan, F. H., Fariha, M. M. N., Ismail, Z., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.943427 · Cited by 171
“On the other hand, a decrease in abundance of this bacterium increases gut permeability, a known characteristic in T2DM progression (Cani et al., 2008).”
BackgroundMicrobiota, Inflammation and Obesity
Sanz, Y., & Moya-Pérez, Á. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_14 · Cited by 166
Toll-like receptors, inflammation, metabolism and obesity
Fresno, M., Alvarez, R., & Cuesta, N. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.562514 · Cited by 148
“The LPS produced in the gut can be translocated into intestinal capillaries by a TLR4-dependent mechanism, and transported to target tissues where it will bind TLR4 receptors and trigger inflammatory molecules (Cani et al., 2008).”
BackgroundInfluentialStenman, L. K., Waget, A., Garret, C., Klopp, P., Burcelin, R., & Lahtinen, S. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0014 · Cited by 147
“As germ-free mice are resistant to obesity caused by a HFD (Backhed et al. , 2007; Rabot et al. , 2010), the gut microbiota and gut-derived endotoxins have been proposed to participate in the development of diet-induced obesity in mice.”
InfluentialSelf-citationPathophysiological role of host microbiota in the development of obesity
Kobyliak, N., Virchenko, O., & Falalyeyeva, T. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0166-9 · Cited by 149
“Moreover, mice deficient in LPS receptor (Cd14-/-) tend to be resistant to this chronic inflammatory state and are hypersensitive to insulin even when they are fed a normal diet, suggesting that CD14 may modulate insulin sensitivity under physiological conditions [55].”
BackgroundEnvironmental factors in autoimmune diseases and their role in multiple sclerosis
Haase, S., Grohme, D. A., Erzler, M., Binsfeld, M., Haghikia, A., Müller, D. N., Linker, R. A., & Kleinewietfeld, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2311-1 · Cited by 168
“It was shown that a dysbiotic microbiome could lead to Treg deficiency and an activation of proinflammatory Th17 cells [106, 107].”
BackgroundMa, L., Li, H., Hu, J., Zheng, J., Zhou, J., Botchlett, R., Matthews, D., Zeng, T., Chen, L., Xiao, X., et al. (2020) · Hepatology · doi:10.1002/hep.31115 · Cited by 147
Mao, T., Huang, F., Zhu, X., Wei, D., & Chen, L. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104500 · Cited by 216
Huang, D., Zhang, Y., Long, J., Yang, X., Li, B., Yang, Z., Wu, B., Si, R., Zhao, W., Peng, C. Y., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155937 · Cited by 176
Impact of the Gut Microbiota on the Development of Obesity: Current Concepts
DiBaise, J. K., Frank, D. N., & Mathur, R. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.5 · Cited by 147
Sun, J., Wang, F., Ling, Z., Yu, X., Chen, W., Li, H., Jin, J., Pang, M., Zhang, H., Yu, J., et al. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.042 · Cited by 155
Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats
Wang, Y., Yao, W., Li, B., Qian, S., Wei, B., Gong, S., Wang, J., Liu, M., & Wei, M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00534-2 · Cited by 156
de Lartigue, G., de La Serre, C. B., & Raybould, H. E. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.02.040 · Cited by 146
Zhao, B., Wu, J., Li, J., Bai, Y., Luo, Y., Ji, B., Xia, B., Liu, Z., Tan, X., Lv, J., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c00196 · Cited by 149
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
Wang, Z., Li, Y., Liao, W., Huang, J., Liu, Y., Li, Z., & Tang, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.935723 · Cited by 180
“Changes in the gut microbiota can increase intestinal permeability, leading to changes in LPS entering the circulatory system, thereby controlling metabolic endotoxemia, inflammation, and related diseases (Cani et al., 2008).”
BackgroundEffects of dietary fibre on metabolic health and obesity
Deehan, E. C., Mocanu, V., & Madsen, K. L. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00891-z · Cited by 191
Diet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
Feng, W., Wang, H., Zhang, P., Gao, C., Tao, J., Ge, Z., Zhu, D., & Bi, Y. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.03.017 · Cited by 145
Macrophages, Meta-Inflammation, and Immuno-Metabolism
Shapiro, H., Lutaty, A., & Ariel, A. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/397971 · Cited by 145
“A high-fat meal also facilitates absorption of intestinal LPS and promotes low-grade systemic [102] and AT [101, 103].”
BackgroundMaitra, U., Deng, H., Glaros, T., Baker, B., Capelluto, D. G. S., Li, Z., & Li, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200857 · Cited by 145
Mokkala, K., Röytiö, H., Munukka, E., Pietilä, S., Ekblad, U., Rönnemaa, T., Eerola, E., Laiho, A., & Laitinen, K. (2016) · Journal of Nutrition · doi:10.3945/jn.116.235358 · Cited by 162
The association of type II diabetes with gut microbiota composition
Navab-Moghadam, F., Sedighi, M., Khamseh, M. E., Alaei-Shahmiri, F., Talebi, M., Razavi, S., & Amirmozafari, N. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.07.034 · Cited by 144
Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study
Sato, J., Kanazawa, A., Azuma, K., Ikeda, F., Goto, H., Komiya, K., Kanno, R., Tamura, Y., Asahara, T., Takahashi, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12535-9 · Cited by 144
Chlorogenic Acid-Induced Gut Microbiota Improves Metabolic Endotoxemia
Ye, X., Liu, Y., Hu, J., Gao, Y., Ma, Y., & Wen, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.762691 · Cited by 161
“Changes in the gut microbiota have been associated with a decrease in the serum LPS level (40).”
BackgroundIlmonen, J., Isolauri, E., Poussa, T., & Laitinen, K. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2010.09.009 · Cited by 144
Linking What We Eat to Our Mood: A Review of Diet, Dietary Antioxidants, and Depression
Huang, Q., Liu, H., Suzuki, K., Ma, S., & Liu, C. (2019) · Antioxidants · doi:10.3390/antiox8090376 · Cited by 144
Valentini, L., Pinto, A., Bourdel-Marchasson, I., Ostan, R., Brigidi, P., Turroni, S., Hrelia, S., Hrelia, P., Bereswill, S., Fischer, A., et al. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.09.023 · Cited by 144
“It has been proposed that age-related changes in gut microbiota, associated with an increase in systemic inflammation [10], may also contribute to the progression of disease and frailty in older people [11].”
BackgroundBahr, S. M., Weidemann, B. J., Castro, A. N., Walsh, J. W., deLeon, O., Burnett, C. M. L., Pearson, N. A., Murry, D. J., Grobe, J. L., & Kirby, J. R. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.018 · Cited by 143
“Interestingly, members of this family have been shown in several independent studies to change in abundance in response to dietary fat intake (Cani et al., 2008; Fleissner et al., 2010; Turnbaugh et al., 2008).”
BackgroundDifferences in the gut microbiota of healthy children and those with type 1 diabetes
Soyucen, E., Gulcan, A., Aktuglu‐Zeybek, A. C., Onal, H., Kiykim, E., & Aydin, A. (2014) · Pediatrics International · doi:10.1111/ped.12243 · Cited by 144
John, G., Wang, L., Nanavati, J., Twose, C., Singh, R., & Mullin, G. (2018) · Genes · doi:10.3390/genes9030167 · Cited by 145
“Prebiotic supplementation improves the gut barrier by allowing the proliferation of commensal gut flora and has been shown to reduce the levels of inflammatory cytokines in animal studies [67].”
BackgroundIntestinal microbiota and the immune system in metabolic diseases
Sittipo, P., Lobionda, S., Lee, Y. K., & Maynard, C. L. (2018) · Journal of Microbiology · doi:10.1007/s12275-018-7548-y · Cited by 141
“…disruption of the tight junctions of intestinal epithelial cells has been found to increase bacterial translocation, resulting in the circulation of LPS, increase in plasma LPS, and endotoxemia, which can activate the immune response and insulin resistance (Cani et al., 2008; Kim et al., 2012).”
BackgroundUnravelling the involvement of gut microbiota in type 2 diabetes mellitus
Arora, A., Behl, T., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Sobarzo‐Sánchez, E., & BUNGAU, S. G. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119311 · Cited by 159
Microbiota revolution: How gut microbes regulate our lives
Colella, M., Charitos, I. A., Ballini, A., Cafiero, C., Topi, S., Palmirotta, R., & Santacroce, L. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i28.4368 · Cited by 182
Probiotics as Complementary Treatment for Metabolic Disorders
Le Barz, M., Anhê, F. F., Varin, T. V., Desjardins, Y., Levy, E., Roy, D., Urdaci, M. C., & Marette, A. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.291 · Cited by 142
“[6] were the first group to demonstrate a positive correlation between alteration of gut microbiota population, the increase of intestinal permeability and the development of metabolic endotoxemia that is characterized by the translocation of bacterial lipopolysaccharides (LPSs) into the systemic circulation and induc…”
BackgroundMicrobiota, NASH, HCC and the potential role of probiotics
Brandi, G., De Lorenzo, S., Candela, M., Pantaleo, M. A., Bellentani, S., Tovoli, F., Saccoccio, G., & Biasco, G. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx007 · Cited by 142
Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
Poeta, M., Pierri, L., & Vajro, P. (2017) · Children · doi:10.3390/children4080066 · Cited by 162
“Schematically, possible actions on GLA may include GM manipulation through prebiotics (substances useful to the growth of good GM), probiotics (live microorganisms), and synbiotics (combining probiotics and prebiotics in a form of synergism), that appear to reduce intestinal inflammation and improve the epithelial bar…”
BackgroundLeaky brain in neurological and psychiatric disorders: Drivers and consequences
Morris, G., Fernandes, B. S., Puri, B. K., Walker, A. J., Carvalho, A. F., & Berk, M. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418796955 · Cited by 142
Portincasa, P., Khalil, M., Mahdi, L., Perniola, V., Idone, V., Graziani, A., Baffy, G., & Ciaula, A. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115640 · Cited by 183
“Inflammatory mediators, including endotoxin, originate from the gut microbiota [179], especially in the context of a high-fat diet, where endotoxin level is increased [180,181].”
BackgroundGut inflammation in chronic fatigue syndrome
Lakhan, S. E., & Kirchgessner, A. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-79 · Cited by 143
“Normally, the intestinal epithelium acts as a continuous barrier to avoid LPS translocation; however, some endogenous or exogenous events may alter this protective function [37].”
Immuno-microbiota cross and talk: The new paradigm of metabolic diseases
Burcelin, R., Garidou, L., & Pomié, C. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2011.11.011 · Cited by 157
“Similar results were found in mice [23] and in mutant mice such as in leptin deficient mice even feeding on a normal diet [36] suggesting that a change in intestinal permeability to LPS could be a regulatory mechanism [36,37].”
BackgroundResultSelf-citationVemuri, R., Gundamaraju, R., Shastri, M. D., Shukla, S. D., Kalpurath, K., Ball, M., Tristram, S., Shankar, E. M., Ahuja, K., & Eri, R. (2018) · BioMed Research International · doi:10.1155/2018/4178607 · Cited by 141
Host/microbiota interactions in health and diseases—Time for mucosal microbiology!
Daniel, N., Lécuyer, E., & Chassaing, B. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00383-w · Cited by 165
Jung, S.-P., Lee, K.-M., Kang, J.-H., Yun, S.-I., Park, H.-O., Moon, Y., & Kim, J.-Y. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.2.80 · Cited by 140
Evidence for the effects of yogurt on gut health and obesity
Pei, R., Martin, D. A., DiMarco, D. M., & Bolling, B. W. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.883356 · Cited by 138
“Obesity-associated dysregulation of gut microbiota may also increase endotoxin exposure (Cani et al., 2007; Cani et al., 2008).”
BackgroundFluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance
Henriksbo, B. D., Lau, T. C., Cavallari, J. F., Denou, E., Chi, W., Lally, J. S., Crane, J. D., Duggan, B. M., Foley, K. P., Fullerton, M. D., et al. (2014) · Diabetes · doi:10.2337/db13-1398 · Cited by 139
“It is enticing to speculate that metabolic endotoxemia or other priming agents for the inflammasome may play a role (27).”
BackgroundPlieskatt, J. L., Deenonpoe, R., Mulvenna, J. P., Krause, L., Sripa, B., Bethony, J. M., & Brindley, P. J. (2013) · The FASEB Journal · doi:10.1096/fj.13-232751 · Cited by 140
“Alterations in microbiota have systemic effects on glucose tolerance, body weight, fat mass, oxidative stress, and macrophage infiltration marker expression in visceral adipose tissue (68).”
BackgroundDelzenne, N. M., Knudsen, C., Beaumont, M., Rodriguez, J., Neyrinck, A. M., & Bindels, L. B. (2019) · Proceedings of the Nutrition Society · doi:10.1017/s0029665118002756 · Cited by 139
“Since many tryptophan-derived bacterial metabolites beneficially control intestinal permeability and mucosal immunity(58,59), these compounds could limit the translocation of harmful microbiota-derived components (LPS, peptidoglycan, etc.) from the gut to the liver.”
BackgroundInfluentialSelf-citationZhang, B., Sun, W., Yu, N., Sun, J., Yu, X., Li, X., Xing, Y., Yan, D., Ding, Q., Xiu, Z., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.070 · Cited by 145
The role of adipose tissue senescence in obesity- and ageing-related metabolic disorders
Liu, Z., Wu, K. K. L., Jiang, X., Xu, A., & Cheng, K. K. Y. (2020) · Clinical Science · doi:10.1042/cs20190966 · Cited by 137
Gut microbiome, prebiotics, intestinal permeability and diabetes complications
Snelson, M., de Pasquale, C., Ekinci, E. I., & Coughlan, M. T. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101507 · Cited by 154
Soy and Gut Microbiota: Interaction and Implication for Human Health
Huang, H., Krishnan, H. B., Pham, Q., Yu, L. L., & Wang, T. T. Y. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b03725 · Cited by 138
DiPatrizio, N. V. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0001 · Cited by 136
Singh, D. P., Singh, J., Boparai, R. K., Zhu, J., Mantri, S. S., Khare, P., Khardori, R. K., Kondepudi, K. K., Chopra, K., & Bishnoi, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.06.015 · Cited by 144
High-Fat Diet Changes Fungal Microbiomes and Interkingdom Relationships in the Murine Gut
Heisel, T., Montassier, E., Johnson, A., Al-Ghalith, G., Lin, Y.-W., Wei, L.-N., Knights, D., & Gale, C. A. (2017) · mSphere · doi:10.1128/msphere.00351-17 · Cited by 138
“Proposed mechanisms for microbially mediated obesity effects include increased energy extraction from the diet (6, 7), production of neuroactive factors that decrease satiety or increase hunger (8, 9), and induced inflammatory responses (10).”
BackgroundImportance of gut microbiota in obesity
Cornejo-Pareja, I. M., Muñoz‐Garach, A., Clemente‐Postigo, M., & Tinahones, F. J. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0306-8 · Cited by 163
Liu, J., Hao, W., He, Z., Kwek, E., Zhao, Y., Zhu, H., Liang, N. N., Ma, K. Y., Lei, L., He, W., et al. (2019) · Food & Function · doi:10.1039/c8fo02051e · Cited by 157
The Gut Microbiome and Multiple Sclerosis
Ochoa‐Repáraz, J., Kirby, T. O., & Kasper, L. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029017 · Cited by 146
“Thus, the effects of dysbiosis on the intestinal integrity could affect significantly the levels of gut microbial components, such as endotoxin (Cani et al. 2008), and exacerbate disease.”
BackgroundMechanistic links between gut microbial community dynamics, microbial functions and metabolic health
Ha, C. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16498 · Cited by 137
Oliveira, A. G., Carvalho, B. M., Tobar, N., Ropelle, E. R., Pauli, J. R., Bagarolli, R. A., Guadagnini, D., Carvalheira, J. B. C., & Saad, M. J. A. (2011) · Diabetes · doi:10.2337/db09-1907 · Cited by 137
“(13) recently hypothesized that bacterial LPS, derived from Gram-negative bacteria residing in the gut microbiota, acts as a triggering factor, linking inflammation to high-fat diet–induced diabetes and obesity.”
BackgroundRetractedDuarte, S. M. B., Stefano, J. T., Miele, L., Ponziani, F. R., de Souza-Basqueira, M., Okada, L. S. R. R., Costa, F., Toda, K., Mazo, D. F. D. C., Sabino, É. C., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.014 · Cited by 143
Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases
Bilski, J., Mazur-Biały, A. I., Wójcik-Grzybek, D., Surmiak, M., Magierowski, M., Śliwowski, Z., Pajdo, R., Kwiecień, S., Danielak, A., Ptak‐Belowska, A., et al. (2019) · Biomolecules · doi:10.3390/biom9120780 · Cited by 161
de La Serre, C. B., de Lartigue, G., & Raybould, H. E. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.10.032 · Cited by 136
“High fat fed animals have also been observed to develop vagal leptin resistance [13,20] and metabolic endotoxemia [6,10,37].”
BackgroundCheng, M., Zhang, X., Miao, Y., Cao, J., Wu, Z., & Weng, P. (2016) · Food Research International · doi:10.1016/j.foodres.2016.12.008 · Cited by 143
Bridgewater, L. C., Zhang, C., Wu, Y., Hu, W., Zhang, Q., Wang, J., Li, S., & Zhao, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-11069-4 · Cited by 135
Berberine Modulates Gut Microbiota and Reduces Insulin Resistance via the TLR4 Signaling Pathway
Liu, D., Zhang, Y., Liu, Y., Hou, L., Li, S., Tian, H., & Zhao, T. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-125066 · Cited by 136
“Gut microbiota dysbiosis, especially a reduction in the abundance of gut barrier-protecting bacteria such as Bifidobacte - rium and an enrichment of Gram-negative endotoxin producing bacteria such as Escherichia coli., may lead to impaired intestinal barrier integrity and increased plasma LPS [31].”
Wang, L., Zeng, B., Liu, Z., Liao, Z., Zhong, Q., Gu, L., Wei, H., & Fang, X. (2018) · Journal of Food Science · doi:10.1111/1750-3841.14058 · Cited by 136
Konjaku flour reduces obesity in mice by modulating the composition of the gut microbiota
Kang, Y., Li, Y., Du, Y., Guo, L., Chen, M., Huang, X., Fang, Y., Hong, J., & Kong, X. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0187-x · Cited by 148
Akkermansia muciniphila : is it the Holy Grail for ameliorating metabolic diseases?
Yan, J., Sheng, L., & Li, H. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1984104 · Cited by 154
Kirpich, I. A., Feng, W., Wang, Y., Liu, Y., Barker, D. F., Barve, S. S., & McClain, C. J. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01673.x · Cited by 135
“Our data and results from previously published studies in nonalcoholic fatty liver disease (Cani et al., 2008) clearly demonstrate that the amount of fat in a diet and its composition can also significantly modulate the intestinal TJ.”
BackgroundResultMicrobiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity
Remely, M., Aumueller, E., Jahn, D., Hippe, B., Brath, H., & Haslberger, A. G. (2014) · Beneficial Microbes · doi:10.3920/bm2013.006 · Cited by 135
Getachew, B., Aubee, J. I., Schottenfeld, R. S., Csoka, A. B., Thompson, K. M., & Tizabi, Y. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1373-7 · Cited by 134
Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
Di Marzo, V., & Silvestri, C. (2019) · Nutrients · doi:10.3390/nu11081956 · Cited by 135
“The term “leaky gut” has been used to describe the phenomenon in which the tight junctions within the intestinal epithelial lining are compromised, leading to the movement of bacterially derived LPS into circulation, resulting in metabolic endotoxemia-induced inflammation that is associated with obesity [84,85].”
BackgroundTargeting gut microbiota as a possible therapy for diabetes
He, C., Shan, Y., & Song, W. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.03.002 · Cited by 146
“Additionally, antibiotic treatment significantly reduces the numbers of Lactobacillus spp, Bifidobacterium spp, and Bacteroides-Prevotella spp in ob/ob mice [34].”
BackgroundInfluentialAlteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing
Chen, X., Sun, H., Jiang, F., Shen, Y., Li, X., Hu, X., Shen, X., & Wei, P. (2020) · PeerJ · doi:10.7717/peerj.8317 · Cited by 133
“of circulating lipopolysaccharide, which contribute to increase the incidence of obesity (Cani et al., 2008).”
BackgroundWang, T., Han, J., Dai, H., Sun, J., Ren, J., Wang, W., Qiao, S., Liu, C., Sun, L., Liu, S., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119862 · Cited by 144
Huang, E. Y., Leone, V. A., Devkota, S., Wang, Y., Brady, M. J., & Chang, E. B. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113486931 · Cited by 133
Poulsen, M. M., Fjeldborg, K., Ørnstrup, M. J., Kjær, T. N., Nøhr, M. K., & Pedersen, S. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.024 · Cited by 146
“DAPK1 inhibits NF-kB activation and pro-inflammatory cytokine expression after stimulation with LPS and TNFa: however, other studies have reported a pro-inflammatory effect of DAPK1.”
InfluentialEsteve, E., Ricart, W., & Fernández-Real, J.-M. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328348c06d · Cited by 133
Implication of Fructans in Health: Immunomodulatory and Antioxidant Mechanisms
Franco-Robles, E., & López, M. G. (2015) · The Scientific World Journal · doi:10.1155/2015/289267 · Cited by 133
“Fructans have been proposed as modulators of the microbial ecology and host physiology in animals and humans [33, 34] because they are not digested [9].”
BackgroundToral, M., Gómez-Guzmán, M., Jiménez, R., Romero, M., Sánchez, M., Utrilla, M. P., Garrido-Mesa, N., Rodríguez-Cabezas, M. E., Olivares, M., Gálvez, J., et al. (2014) · Clinical Science · doi:10.1042/cs20130339 · Cited by 132
Hulston, C. J., Churnside, A. A., & Venables, M. C. (2015) · British Journal of Nutrition · doi:10.1017/s0007114514004097 · Cited by 133
“decreased gut barrier function) have been observed in animal models of insulin resistance and type 2 diabetes((5,6)).”
High dietary fat intake induces a microbiota signature that promotes food allergy
Hussain, M., Bonilla‐Rosso, G., Chung, C. K. C. K., Bäriswyl, L., Rodriguez, M. P., Kim, B., Engel, P., & Noti, M. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.01.043 · Cited by 145
Widespread sex dimorphism in aging and age-related diseases
Sampathkumar, N. K., Bravo, J. I., Chen, Y., Danthi, P. S., Donahue, E. K., Lai, R. W., Lu, R., Randall, L. T., Vinson, N., & Benayoun, B. A. (2020) · Human Genetics · doi:10.1007/s00439-019-02082-w · Cited by 131
Vlieg, J. E. V. H., Veiga, P., Zhang, C., Derrien, M., & Zhao, L. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.12.004 · Cited by 147
Role of macrophage tissue infiltration in obesity and insulin resistance
Bourlier, V., & Bouloumié, A. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.05.001 · Cited by 161
“[59] Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al.”
BackgroundStehle, J. R., Leng, X., Kitzman, D. W., Nicklas, B. J., Kritchevsky, S. B., & High, K. P. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls178 · Cited by 131
The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders?
Ochoa-Repáraz, J., & Kasper, L. H. (2016) · Current Obesity Reports · doi:10.1007/s13679-016-0191-1 · Cited by 132
Kang, C., Zhang, Y., Zhu, X., Liu, K., Wang, X., Chen, M., Wang, J., Chen, H., Hui, S., Huang, L., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2786 · Cited by 131
Bo, T., Wen, J., Zhao, Y.-C., Tian, S.-J., Zhang, X., & Wang, D. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105602 · Cited by 144
Xu, L., Zhang, Y., Li, X., Li, C., Hu, H., Hu, J., Liu, M., Yang, Q. Z., Gu, P., Li, J., et al. (2025) · iMeta · doi:10.1002/imt2.270 · Cited by 154
Marcotorchino, J., Romier, B., Gouranton, E., Riollet, C., Gleize, B., Malezet‐Desmoulins, C., & Landrier, J. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100623 · Cited by 131
Obesity and the gastrointestinal microbiota: a review of associations and mechanisms
Graham, C., Mullen, A., & Whelan, K. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv004 · Cited by 131
Metadata
- Authors
- Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R.
- Affiliations
- UCLouvain (BE)
- Nestlé (Switzerland) (CH)
- Rangueil Institute of Molecular Medicine, Toulouse, France
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-06-01
- Volume
- 57
- Issue
- 6
- Pages
- 1470-1481
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2129917444
- Cited by
- 4,819
- References
- 47
- Citations by year
- 2026: 223 · 2025: 240 · 2024: 305 · 2023: 319 · 2022: 397 · 2021: 420 · 2020: 389 · 2019: 396 · 2018: 368 · 2017: 319 · 2016: 319 · 2015: 292 · 2014: 199 · 2013: 187 · 2012: 149
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Digital Access to Libraries (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-PNRA-004, ANR-05)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, metabolic endotoxemia, lipopolysaccharide, high-fat diet, obesity, type 2 diabetes, low-grade inflammation, antibiotic therapy, intestinal permeability, tight junctions, CD14, visceral adipose tissue, oxidative stress, impaired glucose tolerance, ob/ob mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteroides, Base Sequence, Bifidobacterium, Cecum, Crosses, Genetic, Diabetes Mellitus, Experimental, Feces, Female, Genotype, Inflammation, Lactobacillus, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, RNA, Bacterial, Endotoxemia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.